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Since it was a final year of this study, the meeting 
for the total conclusion was held. Furthermore, the outline 
about the effects of low dose tritium on living body was 
published1)2)3). Therefore, to prepare the data for biological 
effects of low dose tritium, the present report focused on, i) 
analysis of biological effects of tritium by using genetically 
engineered animals, ii) analysis of the mechanism of DNA 
damage response, and iii) analysis of the biological effects 
of tritium at the cellular level. Followings are summary of 
the results for 3 years. 
i) Analysis of biological effects of tritium by using 
genetically engineered animals 
 We have established a novel experimental system 
that can examine the biological effects of low dose (rate) 
tritium radiation at animal level. We used two strains of 
transgenic mice, the gpt-delta mice4) and Rev1 mice5). The 
gpt-delta mice carry a mutation reporter gene, and Rev1 
mice are over-expressing Rev1. We also used the p53 (a 
tumor suppressor gene) knockout mice6), in order to clarify 
the importance of the regulation of DNA damage 
checkpoint in prevention of teratogenic effects by low dose 
tritium exposure. Tritiated water (HTO) was administrated 
to the gpt-delta mice at low dose rate, and the mutation 
frequency at several tissues are analyzed. With the total 
dose of 3 Gy, the mutant frequency was elevated 
approximately 2-fold above control level, and it remained 
at a similar level up to 6 Gy. These results indicate that gpt 
delta mouse could be a good model animal to study 
genotoxicity (induction of mutation) of tritium. 
ii) Analysis of the mechanism of DNA damage response 
Understanding the molecular mechanism of 
cellular DNA damage responses is another important point 
of view to understand the biological risk of low dose (rate) 
radiation. If the mechanisms are fully clarified, we believe 
that one can simulate the biological responses to low dose 
tritium radiation.  
Activation of the DNA-dependent protein kinase 
(DNA-PK) and AKT signaling pathway was found in 
cellular response to X-ray exposure. Therefore, we tested 
whether the pathway is also activated by HTO exposure. 
As well as X-rays, exposure of HepG2 and HeLa cells to 
HTO activated AKT, which was shown by phosphorylated-
AKT at Serine 473 residue. The activation of DNA-PK was 
also observed in these cells by X-ray irradiation but not by 
exposure to HTO7)(Fig.1). These suggest the existence of 
difference in cellular response between X-rays and HTO.  
iii) Analysis of the biological effects of tritium at the 
cellular level 
We previously found that the human-X-carrying 
hamster cell system appeared to be able to detect a wide 
range of mutation spectrum, even if those mutations affect 
the expression of important human genes for cell survival. 
The system showed about 100-fold sensitivity compared to 
the conventional system that uses endogenous Hprt gene.
By using the cell system, we are testing the mutation 
induction by HTO exposure at low dose rate. Our results 
suggested that the reverse dose rate effect does not apply in 
the case of mutation induction by HTO and that exposure 
to low level of HTO (0.1 Gy with 12mGy/day) could 
merely enhance the spontaneous mutagenesis8)(Fig.2).
We have demonstrated that the recognition of 
primary-dose and adaptive response could be mediated by a 
feedback signal pathway which involves protein kinase C 
(PKC), p38 mitogen activated protein kinase (p38/MAPK), 
and phospholipase C (PLC). We are doing experiments to 
clarify the effect of PKC knockdown by siRNA on radio-
adaptive response. By the experiments, we may verify the 
importance of PKC pathway for expression of radio-
adaptive responses. In addition, we found that an adaptive 
response was induced by pre-treatment of the cells with 
low concentration of tritium compound such as 3H-
thymidine for a few days9).
 
 
 
 
Fig. 2. Dose-rate dependency of mutation frequency 
induced by exposure to HTO. 
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Fig. 1. Activation of the AKT signaling pathway by HTO. 
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